Prognostic perform- ance of multiple biomarkers in patients with non-ST-segment ele- vation acute coronary syndrome:analysis from the MERLIN-TIMI 36 trial(metabolic efficiency with ranolazine for less ischemia in non-ST-elevation acute coronary syndromes-thrombolysis in myo- cardial infarction 36)

查看全文 作　　者：O:Malley RG; Bonaca MP; Scirica BM; 出　　处：《J Am Colle Cardiol》索引2014年第63卷第16期,共0页